LINC01990: A Potential Drug Target and Biomarker (G101929607)

Target Name: LINC01990

NCBI ID: G101929607

LINC01990

Other Name(s): Long intergenic non-protein coding RNA 1990 | long intergenic non-protein coding RNA 1990

LINC01990: A Potential Drug Target and Biomarker

Non-protein coding RNAs (ncRNAs) have emerged as a promising area of research in recent years due to their involvement in various cellular processes. One of these ncRNAs, LINC01990, has shown great potential as a drug target and biomarker. In this article, we will explore the biology of LINC01990, its potential as a drug target, and its potential as a biomarker for various diseases.

The LINC01990 gene

LINC01990 is a non-protein coding RNA that was identified in the human genome by RNA-seq experiments. It has a length of 211 nucleotides and is located on chromosome 6 (chr6) at position 1990. LINC01990 is a small RNA molecule that is expressed in various tissues and cells of the body.

Expression of LINC01990

LINC01990 is highly expressed in the brain, heart, and testes, and is also expressed in other tissues and organs. It is primarily expressed in the brain, where it is highly expressed in the prefrontal cortical tissue. LINC01990 is also expressed in the heart, where it is expressed in the cardiac muscle tissue. Additionally, LINC01990 is expressed in the testes, where it is highly expressed in the germinal epithelial tissue.

Function of LINC01990

LINC01990 is involved in various cellular processes that are essential for human health. One of its functions is involved in the regulation of cell adhesion. LINC01990 has been shown to be involved in the formation of tight junctions, which are essential for the proper functioning of epithelial cells.

Another function of LINC01990 is involved in the regulation of cell proliferation. LINC01990 has been shown to be involved in the regulation of cell proliferation by promoting the expression of the proliferation-associated protein (PAX), which is a critical regulator of cell proliferation.

Potential as a drug target

The potential of LINC01990 as a drug target is due to its involvement in various cellular processes that are crucial for human health. LINC01990 has been shown to be involved in the regulation of cell adhesion, which is a critical process for the proper functioning of various tissues. Additionally, LINC01990 has been shown to be involved in the regulation of cell proliferation, which is essential for the growth and development of tissues.

Due to its involvement in these critical cellular processes, LINC01990 has great potential as a drug target. Drugs that target LINC01990 have the potential to treat various diseases, including cancer, neurodegenerative diseases, and developmental disorders.

Potential as a biomarker

LINC01990 has also been shown to have the potential as a biomarker for various diseases. Its expression has been shown to be associated with various diseases, including cancer, neurodegenerative diseases, and developmental disorders.

For example, LINC01990 has been shown to be highly expressed in various types of cancer, including breast, lung, and ovarian cancer. Additionally, LINC01990 has been shown to be involved in the regulation of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.

In conclusion, LINC01990 is a non-protein coding RNA that has shown great potential as a drug target and biomarker. Its involvement in various cellular processes that are essential for human health makes it an attractive target for drug development. Additionally, its potential as a biomarker for various diseases makes it an important tool for the diagnosis and treatment of disease. Further research is needed to fully understand the biology of LINC01990 and its potential as a drug

Protein Name: Long Intergenic Non-protein Coding RNA 1990

The "LINC01990 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01990 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets